HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (1,6- dideoxyfructopyranosyl)- 1,3- dioleoyl- 2- phosphatidylethanolamine

structure in first source

Also Known As:

Amadori-PE; deoxy-D-fructosyl PE

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycolipids: 2799
    - N-(1,6-dideoxyfructopyranosyl)-1,3-dioleoyl-2-phosphatidylethanolamine: 4
Lipids: 114793
- Glycolipids: 2799
  - N-(1,6-dideoxyfructopyranosyl)-1,3-dioleoyl-2-phosphatidylethanolamine: 4
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - Glycerophosphates: 118
      - Phosphatidic Acids: 358
        Glycerophospholipids: 689
        Phosphatidylethanolamines: 167
        N-(1,6-dideoxyfructopyranosyl)-1,3-dioleoyl-2-phosphatidylethanolamine: 4

Experts

1.	Miyazawa, Teruo: 4 articles (07/2012 - 12/2003)
2.	Nakagawa, Kiyotaka: 4 articles (07/2012 - 12/2003)
3.	Shoji, Naoki: 2 articles (07/2012 - 10/2011)
4.	Oak, Jeong-Ho: 2 articles (06/2005 - 12/2003)
5.	Eitsuka, Takahiro: 1 article (07/2012)
6.	Kurata, Tadao: 1 article (07/2012)
7.	Nishida, Hiroshi: 1 article (07/2012)
8.	Ono, Yuichi: 1 article (07/2012)
9.	Tatewaki, Naoto: 1 article (07/2012)
10.	Fujita, Ikuko: 1 article (10/2011)

Related Diseases

1.	Pancreatic Neoplasms (Pancreatic Cancer) 07/30/2012 - "The purpose of this study was to obtain new information about the effect of Amadori-PE on the regulation of telomerase in PANC-1 human pancreatic carcinoma cells. "
2.	Vascular Diseases (Vascular Disease) 12/04/2003 - "Our results demonstrated for the first time that Amadori-PE may be an important compound that promotes vascular disease as a result of its angiogenic activity on endothelial cells. " 06/01/2005 - "Our results indicated for the first time that Amadori-PE would elicit vascular disease through angiogenic potency on endothelial cells, thereby playing an active part in the development and progression of diabetic microangiopathy."
3.	Diabetes Complications 07/30/2012 - "Several lines of experimental data have highlighted a key role of Amadori-glycated phosphatidylethanolamine (Amadori-PE) in the development of diabetic complications. "
4.	Neoplasms (Cancer) 07/30/2012 - "These results provide experimental evidence for a novel role of Amadori-PE in linking diabetes and cancer."
5.	Hyperglycemia 10/01/2011 - "Our results suggest that Amadori-PE may be a useful predictive marker for hyperglycemia, particularly in the early stages of diabetes. "

Related Drugs and Biologics

1.	Telomerase (Telomerase Reverse Transcriptase)
2.	phosphatidylethanolamine